Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 7;12(9):1418.
doi: 10.3390/antibiotics12091418.

Utilization of Existing Human Kinase Inhibitors as Scaffolds in the Development of New Antimicrobials

Monika I Konaklieva  1 , Balbina J Plotkin  2
Affiliations
Review

Utilization of Existing Human Kinase Inhibitors as Scaffolds in the Development of New Antimicrobials

Monika I Konaklieva et al. Antibiotics (Basel). .

Abstract

The prevalence and continuing expansion of drug resistance, both in clinical and community settings represents a major challenge for current antimicrobial therapy. The different approaches for addressing this challenge include (1) identification of novel antibacterials by repurposing of existing drugs originally that historically target host proteins; and (2) effect target switching through modification of existing antimicrobials. The focus of this manuscript is on these drug discovery strategies, with utility for development of new antimicrobials with different modes of action.

Keywords: antimicrobials; drug repurposing; drug resistance; human kinase inhibitors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Similar articles

See all similar articles

References

    1. O’Neill J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Government of the United Kingdom; London, UK: 2015. The Review on Antimicrobial Resistance.
    1. CDC . Transcript for VitalSigns Teleconference: Antibiotic Resistant Germs. Center for Disease Control and Prevention; Atlanta, GA, USA: 2018.
    1. Plackett B. Why big pharma has abandoned antibiotics. Nature. 2020;586:S50–S52. doi: 10.1038/d41586-020-02884-3. - DOI
    1. King A., Blackledge M.S. Evaluation of Small Molecule Kinase Inhibitors as Novel Antimicrobial and Antibiofilm Agents. Chem. Biol. Drug Des. 2021;98:1038–1064. doi: 10.1111/cbdd.13962. - DOI - PMC - PubMed
    1. Chen H., Yu C., Wu H., Li G., Li C., Hong W., Yang X., Wang H., You X. Recent Advances in Histidine Kinase-Targeted Antimicrobial Agents. Front. Chem. 2022;10:866392. doi: 10.3389/fchem.2022.866392. - DOI - PMC - PubMed

LinkOut - more resources